<DOC>
	<DOCNO>NCT02054650</DOCNO>
	<brief_summary>The study hypothesis base osteopathic medical philosophy : 1 ) body unit ; 2 ) body inherent self-regulatory mechanism ; 3 ) structure function interrelate ; 4 ) rational treatment base understanding integration concept . Patients type 2 diabetes mellitus often report ache pain people without diabetes . Because osteopathic manual medicine address dysfunction musculoskeletal system , patient chronic low back pain type 2 diabetes mellitus may benefit non-pharmacological treatment reduce pain , thereby reduce stress perhaps provide well clinical control diabetes demonstrate key marker hemoglobin A1c kidney function . This study extension research complete OSTEOPATHIC Trial . Results study publish Annals Family Medicine March/April 2013 .</brief_summary>
	<brief_title>OMT Somatic Dysfunction Chronic Low Back Pain Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description>SPECIFIC AIM 1 : To conduct randomize controlled trial ( RCT ) determine efficacy osteopathic manual treatment ( OMT ) v sham OMT subject type 2 diabetes mellitus ( T2DM ) comorbid chronic low back pain ( LBP ) . This involve 12-week protocol study change response OMT outcomes LBP severity ( primary outcome measure ) , somatic dysfunction , renal function , glycemic control , biomarkers potentially related T2DM . SPECIFIC AIM 2 : Within RCT , corroborate previous finding indicate patient T2DM high prevalence tissue texture abnormalities T11-L2 spinal segmental region determine finding statistically associate presence diabetic nephropathy use laboratory measure serum creatinine , urinary microalbuminuria macroalbuminuria , glomerular filtration rate . SPECIFIC AIM 3 : Within RCT , explore potential mechanism action OMT longitudinally measure concentration biomarkers insulin , glucagon , cortisol , hemoglobin A1c , tumor necrosis factor-α , interleukin ( IL ) -1β , IL-6 , IL-10 , IL-18 subject T2DM comorbid chronic LBP 12 week . Significant change biomarker concentration may help explain effect OMT whether effect mediate change somatic dysfunction .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<criteria>1 . Fasting plasma glucose ≥126 mg/dL ; OR 2 . Oral glucose tolerance test ≥200 mg/dL ; OR 3 . HbA1c ≥6.5 % AND 4 . Low back pain day past three month ; AND 5 . Usual low back pain severity 4 great 11 point numerical scale past week . 1. age less 18 year age great 79 year ; OR 2. previous current diagnosis type 1 diabetes mellitus ; OR 3. history follow pancreatic related disorder : ( ) acute chronic pancreatitis , ( b ) pancreatic tumor cancer , ( c ) ZollingerEllison syndrome , ( ) medical surgical condition result functional hypo hyperglycemia ; OR 4. endstage renal disease ; OR 5. history surgery involve pancreas ; OR 6. history low back surgery past year ; OR 7. receive worker ' compensation benefit past three month ; OR 8. involvement ongoing litigation relate diabetes mellitus back problem ; OR 9. history stroke transient ischemic attack past year ; OR 10. use intravenous , intramuscular oral corticosteroid within past month ; OR 11. attend manual treatment session ( OMT manual therapy deliver chiropractor physical therapist ) past three month , three time past year ; OR 12. practice osteopathic medicine , chiropractic , physical therapy , attend correspond professional school ; OR 13. pregnant ; OR 14. currently participate another medical research study Subjects also exclude follow condition find clinical screening : 1. presence `` red flag '' condition relate LBP ( cancer anatomical site , spinal osteomyelitis , spinal fracture , herniated disc , ankylose spondylitis , cauda equina syndrome ) ; OR 2. angina congestive heart failure symptom minimal activity ; OR 3. active bleed infection lower back , condition might impede protocol implementation ; OR 4. discovery presence telephone screen exclusion criterion ( EXCEPT usual LBP severity past week may decline ≥4/10 point ≥3/10 point lag time screening ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Chronic low back pain</keyword>
	<keyword>Type 2 diabetes mellitus</keyword>
	<keyword>Back pain</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Osteopathic manual treatment</keyword>
	<keyword>Osteopathic manipulative treatment</keyword>
	<keyword>OMT</keyword>
	<keyword>Biomarkers</keyword>
	<keyword>Glycemic control</keyword>
	<keyword>Kidney function</keyword>
</DOC>